Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1987 Jun;31(6):850–853. doi: 10.1128/aac.31.6.850

Systemic absorption of endotracheally administered aminoglycosides in seriously ill patients with pneumonia.

S S Crosby, W A Edwards, C Brennan, E P Dellinger, L A Bauer
PMCID: PMC284198  PMID: 3619417

Abstract

A study was performed with 10 hospitalized patients to determine the percentage of an aminoglycoside dose (tobramycin or gentamicin) that is absorbed systemically after being instilled into the endotracheal tube at steady state. All patients were on respirators, had indwelling urinary catheters, and had creatinine clearances estimated to be greater than or equal to 40 ml/min. Tobramycin or gentamicin (40 mg) was instilled every 4 h directly into the endotracheal tube. Nine patients also received systemically a different aminoglycoside from that administered through the endotracheal tube. Urine was collected over a 4-h dosing interval at steady state (after at least 5 doses of the drug). The amount of aminoglycoside excreted over the 4-h interval was measured and expressed as percentage of the dose administered over that period. The range of percentage of dose absorbed was 1.5 to 34%, with a mean of 16.7 +/- 11.4% standard deviation and a median of 16.5%. The coefficient of variation was 68%. Levels of the endotracheally administered aminoglycoside in serum were measured, and all were less than 1.0 microgram/ml. While a large degree of variability in absorption was observed in this study, significant amounts of aminoglycosides could be absorbed in some patients. However, levels apparently did not accumulate in sera of patients with adequate renal function, and an empirical dosage reduction in intravenous aminoglycoside should not be necessary with the addition of endotracheally instilled aminoglycoside in patients with creatinine clearances greater than 40 ml/min.

Full text

PDF
850

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander M. R., Berglund E. M., Kasik J. E., Fox A., Chinn W. M. The concentration of tobramycin in bronchial secretions. Chest. 1979 Jun;75(6):675–678. doi: 10.1378/chest.75.6.675. [DOI] [PubMed] [Google Scholar]
  2. Alexander M. R., Schoell J., Hicklin G., Kasik J. E., Coleman D. Bronchial secretion concentrations of tobramycin. Am Rev Respir Dis. 1982 Feb;125(2):208–209. doi: 10.1164/arrd.1982.125.2.208. [DOI] [PubMed] [Google Scholar]
  3. Cockcroft D. W., Gault M. H. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41. doi: 10.1159/000180580. [DOI] [PubMed] [Google Scholar]
  4. Ervin F. R., Bullock W. E., Jr, Nuttall C. E. Inactivation of gentamicin by penicillins in patients with renal failure. Antimicrob Agents Chemother. 1976 Jun;9(6):1004–1011. doi: 10.1128/aac.9.6.1004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Klastersky J., Carpentier-Meunier F., Kahan-Coppens L., Thys J. P. Endotracheally administered antibiotics for gram-negative bronchopneumonia. Chest. 1979 May;75(5):586–591. doi: 10.1378/chest.75.5.586. [DOI] [PubMed] [Google Scholar]
  6. Klastersky J., Geuning C., Mouawad E., Daneau D. Endotracheal gentamicin in bronchial infections in patients with tracheostomy. Chest. 1972 Feb;61(2):117–120. doi: 10.1378/chest.61.2.117. [DOI] [PubMed] [Google Scholar]
  7. Lake K. B., Dyke J. J., Rumsfeld J. A. Combined topical pulmonary and systemic gentamicin: The question of safety. Chest. 1975 Jul;68(1):62–64. doi: 10.1378/chest.68.1.62. [DOI] [PubMed] [Google Scholar]
  8. Noone P., Pattison J. R. Therapeutic implications of interaction of gentamicin and penicillins. Lancet. 1971 Sep 11;2(7724):575–578. doi: 10.1016/s0140-6736(71)92152-0. [DOI] [PubMed] [Google Scholar]
  9. Odio W., Van Laer E., Klastersky J. Concentrations of gentamicin in bronchial secretions after intramuscular and endotracheal administration. J Clin Pharmacol. 1975 Jul;15(7):518–524. doi: 10.1002/j.1552-4604.1975.tb01474.x. [DOI] [PubMed] [Google Scholar]
  10. Schentag J. J., Jusko W. J. Renal clearance and tissue accumulation of gentamicin. Clin Pharmacol Ther. 1977 Sep;22(3):364–370. doi: 10.1002/cpt1977223364. [DOI] [PubMed] [Google Scholar]
  11. Smith B. R., LeFrock J. L. Bronchial tree penetration of antibiotics. Chest. 1983 Jun;83(6):904–908. doi: 10.1378/chest.83.6.904. [DOI] [PubMed] [Google Scholar]
  12. Tindula R. J., Ambrose P. J., Harralson A. F. Aminoglycoside inactivation by penicillins and cephalosporins and its impact on drug-level monitoring. Drug Intell Clin Pharm. 1983 Dec;17(12):906–908. doi: 10.1177/106002808301701210. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES